Os Therapies Incorporated Stock Working Capital

OSTX Stock   3.97  0.06  1.53%   
OS Therapies Incorporated fundamentals help investors to digest information that contributes to OS Therapies' financial success or failures. It also enables traders to predict the movement of OSTX Stock. The fundamental analysis module provides a way to measure OS Therapies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OS Therapies stock.
Net Working Capital is likely to rise to about (22.7 M) in 2024. Change In Working Capital is likely to drop to about 1.3 M in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

OS Therapies Incorporated Company Working Capital Analysis

OS Therapies' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

 = 

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current OS Therapies Working Capital

    
  (23.92 M)  
Most of OS Therapies' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OS Therapies Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

OSTX Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for OS Therapies is extremely important. It helps to project a fair market value of OSTX Stock properly, considering its historical fundamentals such as Working Capital. Since OS Therapies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OS Therapies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OS Therapies' interrelated accounts and indicators.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition

OSTX Net Invested Capital

Net Invested Capital

(9.88 Million)

OS Therapies reported Net Invested Capital of (9.41 Million) in 2023
Based on the company's disclosures, OS Therapies Incorporated has a Working Capital of (23.92 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is notably higher than that of the company.

OSTX Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OS Therapies' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OS Therapies could also be used in its relative valuation, which is a method of valuing OS Therapies by comparing valuation metrics of similar companies.
OS Therapies is currently under evaluation in working capital category among its peers.

OSTX Fundamentals

About OS Therapies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze OS Therapies Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OS Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OS Therapies Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.